Capricor Therapeutics, Inc. (CAPR)

NASDAQ: CAPR · Real-Time Price · USD

6.51

+0.30 (4.83%)

At close: Oct 31, 2025, 4:00 PM EST

6.45

-0.06 (-0.92%)

Pre-market: Nov 3, 2025, 8:49 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2009 - 2019
Transformative Cell and Exosome-based Therapeutics	22.27M	Log In	Log In	Log In	Log In	Upgrade
Transformative Cell and Exosome-based Therapeutics Growth	-11.55%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2009 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2009 - 2019
United States	22.27M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-11.55%	Log In	Log In	Log In	Log In	Upgrade